Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parathyroid Hormone | 5 | 2010 | 117 | 1.230 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 4 | 2010 | 6 | 1.140 |
Why?
|
| Kidney Failure, Chronic | 7 | 2010 | 365 | 1.030 |
Why?
|
| Epidermolysis Bullosa Dystrophica | 1 | 2019 | 3 | 0.700 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2019 | 15 | 0.690 |
Why?
|
| Amyloidosis | 1 | 2019 | 48 | 0.670 |
Why?
|
| Kidney Glomerulus | 1 | 2019 | 155 | 0.630 |
Why?
|
| Hypertension | 2 | 2021 | 1535 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1085 | 0.410 |
Why?
|
| Renal Dialysis | 4 | 2010 | 174 | 0.320 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 839 | 0.310 |
Why?
|
| Genes, Immediate-Early | 1 | 2008 | 13 | 0.310 |
Why?
|
| Cytomegalovirus | 1 | 2008 | 63 | 0.290 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 615 | 0.260 |
Why?
|
| Biopsy | 4 | 2019 | 540 | 0.260 |
Why?
|
| Postoperative Complications | 2 | 2021 | 1615 | 0.230 |
Why?
|
| China | 1 | 2021 | 138 | 0.190 |
Why?
|
| Nephrosis, Lipoid | 1 | 2019 | 9 | 0.170 |
Why?
|
| Sclerosis | 1 | 2019 | 32 | 0.170 |
Why?
|
| Calcinosis | 3 | 2010 | 241 | 0.170 |
Why?
|
| Aged | 8 | 2021 | 14862 | 0.160 |
Why?
|
| Blood Pressure | 2 | 2021 | 1451 | 0.150 |
Why?
|
| Humans | 15 | 2021 | 68618 | 0.150 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 514 | 0.150 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 498 | 0.140 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1140 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2010 | 1465 | 0.130 |
Why?
|
| Adult | 8 | 2021 | 21403 | 0.130 |
Why?
|
| Bone Remodeling | 3 | 2010 | 45 | 0.130 |
Why?
|
| Coronary Artery Disease | 2 | 2010 | 696 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2021 | 3705 | 0.110 |
Why?
|
| Cross-Sectional Studies | 5 | 2010 | 2279 | 0.110 |
Why?
|
| Male | 9 | 2021 | 37321 | 0.100 |
Why?
|
| Alkaline Phosphatase | 2 | 2009 | 71 | 0.100 |
Why?
|
| Ilium | 2 | 2009 | 16 | 0.100 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2010 | 43 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2010 | 144 | 0.090 |
Why?
|
| Bone Diseases | 1 | 2010 | 20 | 0.090 |
Why?
|
| Vitamin D Response Element | 1 | 2010 | 2 | 0.090 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2010 | 48 | 0.090 |
Why?
|
| Receptors, Calcitriol | 1 | 2010 | 49 | 0.090 |
Why?
|
| Phosphorus | 1 | 2010 | 64 | 0.090 |
Why?
|
| Immunoassay | 1 | 2010 | 64 | 0.090 |
Why?
|
| Risk Factors | 4 | 2021 | 5731 | 0.090 |
Why?
|
| Middle Aged | 8 | 2021 | 21147 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 146 | 0.090 |
Why?
|
| Transfection | 2 | 2010 | 782 | 0.090 |
Why?
|
| Kidney Diseases | 2 | 2010 | 307 | 0.090 |
Why?
|
| Femur | 1 | 2009 | 113 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 306 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 4848 | 0.080 |
Why?
|
| Bone Density | 1 | 2009 | 159 | 0.080 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2008 | 2 | 0.080 |
Why?
|
| Opossums | 1 | 2008 | 7 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 546 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2008 | 145 | 0.080 |
Why?
|
| Biomarkers | 2 | 2009 | 1593 | 0.070 |
Why?
|
| Blood Chemical Analysis | 1 | 2006 | 43 | 0.070 |
Why?
|
| Calcium | 1 | 2010 | 929 | 0.070 |
Why?
|
| Female | 8 | 2021 | 38074 | 0.070 |
Why?
|
| Registries | 1 | 2009 | 733 | 0.070 |
Why?
|
| Logistic Models | 1 | 2009 | 1420 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 1 | 2006 | 274 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2021 | 714 | 0.060 |
Why?
|
| Algorithms | 1 | 2010 | 1196 | 0.060 |
Why?
|
| Cell Line | 1 | 2008 | 1752 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2006 | 483 | 0.060 |
Why?
|
| Animals | 3 | 2010 | 20881 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 940 | 0.050 |
Why?
|
| Calcification, Physiologic | 2 | 2010 | 31 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2021 | 127 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2021 | 222 | 0.040 |
Why?
|
| Graft Survival | 1 | 2021 | 465 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2021 | 458 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 694 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2010 | 1330 | 0.030 |
Why?
|
| Prognosis | 2 | 2010 | 2093 | 0.030 |
Why?
|
| Age Factors | 2 | 2009 | 1864 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2010 | 64 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2010 | 28 | 0.020 |
Why?
|
| Gene Library | 1 | 2010 | 68 | 0.020 |
Why?
|
| Malnutrition | 1 | 2010 | 28 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 155 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 237 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 214 | 0.020 |
Why?
|
| Porosity | 1 | 2009 | 63 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 7277 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2010 | 152 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 226 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 83 | 0.020 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2008 | 22 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2008 | 36 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2009 | 94 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2009 | 112 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 242 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 167 | 0.020 |
Why?
|
| Young Adult | 2 | 2009 | 5717 | 0.020 |
Why?
|
| Demography | 1 | 2008 | 279 | 0.020 |
Why?
|
| Survival Rate | 1 | 2010 | 1056 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2008 | 308 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 737 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 880 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 792 | 0.020 |
Why?
|
| Inflammation | 1 | 2010 | 1030 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 3259 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1851 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 2007 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 2324 | 0.010 |
Why?
|